Background: Magnetic resonance imaging (MRI) assists with the diagnosis of multiple sclerosis (MS), allows for timely therapeutic intervention, and for the evaluation of disease progression, treatment effect, and safety. An international task force including representatives from the Veterans Health Administration worked together to update guidelines for imaging the brain, spinal cord, and optic nerve in people with MS.

Observations: This commentary communicates the core message of the 2021 MAGNIMS-CMSC-NAIMS Consensus Recommendations on the Use of MRI in Patients With Multiple Sclerosis as part of the MS Center of Excellence effort to align with contemporary guidelines, apply the highest scientific standards, and achieve consistent outcomes for veterans with MS. To implement and disseminate these proposed recommendations within the Veterans Health Administration, a workgroup was formed at the end of 2020, which discussed a modified version of the 2021 MRI Guidelines to accommodate US Department of Veterans Affairs medical centers that had fewer imaging resources as well as veterans' needs.

Conclusions: Standardized MRI protocols are fundamental for the care of veterans with MS. Mitigating interscan variabilities is recognized as a priority by scientific and clinical expert committees.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227743PMC
http://dx.doi.org/10.12788/fp.0251DOI Listing

Publication Analysis

Top Keywords

multiple sclerosis
12
magnetic resonance
8
resonance imaging
8
veterans health
8
health administration
8
veterans
6
harmonizing magnetic
4
imaging
4
imaging protocols
4
protocols veterans
4

Similar Publications

Background: Cognitive deterioration is common in multiple sclerosis (MS) and requires regular follow-up. Currently, cognitive status is measured in clinical practice using paper-and-pencil tests, which are both time-consuming and costly. Remote monitoring of cognitive status could offer a solution because previous studies on telemedicine tools have proved its feasibility and acceptance among people with MS.

View Article and Find Full Text PDF

Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis.

J Neurochem

January 2025

Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.

Aging is the most common risk factor for Multiple Sclerosis (MS) disease progression. Cellular senescence, the irreversible state of cell cycle arrest, is the main driver of aging and has been found to accumulate prematurely in neurodegenerative diseases, including Alzheimer's and Parkinson's disease. Cellular senescence in the central nervous system of MS patients has recently gained attention, with several studies providing evidence that demyelination induces cellular senescence, with common hallmarks of p16INK4A and p21 expression, oxidative stress, and senescence-associated secreted factors.

View Article and Find Full Text PDF

A 16-year-old boy was diagnosed from multiple sclerosis (MS) after suffering from paresthesia in upper limbs and VI cranial nerve paresis. Corticosteroids and fingolimod were started. After 13 months a worsening of liver biochemical tests (LBT) was noticed: ALP 787 U/L, GGT 737 U/L, AST 195, ALT 321, Bi 0.

View Article and Find Full Text PDF

Preliminary validation of CCRacer serious game for assessing executive function after acquired brain injury.

Int J Rehabil Res

January 2025

Department for the Rehabilitation of Patients After TBI, Multiple Sclerosis and Other Neurological Diseases, University Rehabilitation Institute, Linhartova cesta Ljubljana.

Acquired brain injuries can profoundly impact executive functioning, yet traditional neuropsychological assessments often have limitations, such as being time-intensive, lacking ecological validity, or failing to engage patients effectively. To address these challenges, CCRacer, a serious game, was developed as a novel tool for assessing executive functions in clinical populations. This study evaluated the convergent and discriminant validity of CCRacer by applying it alongside established neuropsychological tests to a sample of 78 participants with acquired brain injury.

View Article and Find Full Text PDF

Analysis of Drug-Related Tinnitus Based on the FDA Adverse Event Reporting System Database.

Br J Hosp Med (Lond)

December 2024

Department of Otolaryngology Head and Neck Surgery, Jinhua Hospital of Zhejiang University, Jinhua, Zhejiang, China.

Tinnitus is a very common condition, and is a side effect of many medications. The panorama of drug-induced tinnitus has widened in recent decades, and post-marketing data are needed to gain a better insight into adverse drug reactions related to tinnitus. However, there are currently few studies on drug-induced tinnitus.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!